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Background: Imported horses that have undergone recent long distance transport might represent
a serious risk for spreading infectious respiratory pathogens into populations of horses.
Objective: To investigate the frequency of shedding of respiratory pathogens in recently imported
horses.
Animals: All imported horses with signed owner consent (n5167) entering a USDA quarantine
for contagious equine metritis from October 2014 to June 2016 were enrolled in the study.
Methods: Prospective observational study. Enrolled horses had a physical examination performed
and nasal secretions collected at the time of entry and subsequently if any horse developed signs
of respiratory disease during quarantine. Samples were assayed for equine influenza virus (EIV),
equine herpesvirus type-1, 22, 24, and 25 (EHV-1, 22, 24, 25), equine rhinitis virus A (ERAV),
and B (ERBV) and Streptococcus equi subspecies equi (S. equi) using quantitative PCR (qPCR).
Results: Equine herpesviruses were detected by qPCR in 52% of the study horses including EHV-
2 (28.7%), EHV-5 (40.7%), EHV-1 (1.2%), and EHV-4 (3.0%). Clinical signs were not correlated with
being qPCR-positive for EHV-4, EHV-2, or EHV-5. None of the samples were qPCR-positive for
EIV, ERAV, ERBV, and S. equi. The qPCR assay failed quality control for RNA viruses in 25% (46/
167) of samples.
Conclusions and Clinical Importance: Clinical signs of respiratory disease were poorly correlated
with qPCR positive status for EHV-2, 24, and 25. The importance of g-herpesviruses (EHV-2 and
5) in respiratory disease is poorly understood. Equine herpesvirus type-1 or 4 (EHV-1 or EHV-4)
were detected in 4.2% of horses, which could have serious consequences if shedding animals
entered a population of susceptible horses. Biosecurity measures are important when introducing
recently imported horses into resident US populations of horses.
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1 | INTRODUCTION
Recently imported horses are likely to shed infectious respiratory
pathogens, presenting a risk to resident horses in the United States.
Surveillance studies have shown that equine influenza virus (EIV) and
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equine herpesvirus type-4 (EHV-4) continue to be prevalent viral respi-
ratory pathogens throughout the United States and Europe.1,2 These
highly contagious and virulent respiratory viruses have major financial
implications for the equine industry.3,4
Long distance horse transportation can result in substantial stress
and alteration in immune function, including an acute phase response
that results in impaired cell-mediated immunity.5,6 Imported horses also
have increased exposure risk to infectious respiratory pathogens,
because of comingling at sales/shipping barns, quarantine facilities, and
during transports.
The goal of our study was to determine the detection frequency of
selected infectious respiratory pathogens from horses recently
imported to the United States. Specifically, we analyzed nasal swabs
for shedding of EIV, equine herpesvirus type-1 (EHV-1), equine herpes-
virus type-2 (EHV-2), equine herpesvirus type-4 (EHV-4), equine her-
pesvirus type-5 (EHV-5), Streptococcus equi subsp. equi (S. equi), equine
rhinitis A virus (ERAV), and equine rhinitis B virus (ERBV).
2 | MATERIALS AND METHODS
2.1 | Animals
All horses with owner consent (n5167) admitted to the contagious
equine metritis (CEM) quarantine facility at the Center for Equine
Health, University of California at Davis for CEM quarantine purposes
were enrolled in our study from October 10, 2014 to June 30, 2016.
The USDA approved facility quarantines �200 recently imported
horses on an annual basis. Examination and sample collection was per-
formed �72 hours after having arrived in the United States. Horses
generally spent 48 hours in USDA import quarantine upon arrival at
Los Angeles International Airport, 12 hours in transit to the CEM quar-
antine facility, and 12–18 hours in CEM quarantine before sampling.
2.2 | Sample collection
As part of the routine quarantine protocol, horses entering the quaran-
tine facility had a physical examination performed and blood collected
for a complete blood cell count. The physical examination and blood
draw was performed by a veterinarian from the Equine Field Service of
the UC Davis VMTH. Horses were defined as having clinical signs asso-
ciated with respiratory disease if they had any one: nasal discharge,
tachypnea (respiratory rate >24 breaths per minute), fever (>101.58F),
cough, submandibular or retropharyngeal lymph node enlargement, or
abnormal lung sounds. Data for hematocrit, white blood cell counts,
and fibrinogen were collected from the complete blood counts for each
horse. Additionally, 600 rayon-tipped nasal swabs were collected at the
time of entrance from each horse with informed owner consent.
Horses that developed lethargy, anorexia, fever, excessive nasal dis-
charge, lymphadenopathy, or cough during the quarantine period (14
days for mares, 31 days for stallions) had additional nasal swabs col-
lected at the time of the onset of clinical signs and the pertinent physi-
cal exam changes recorded. The swabs were transferred to tubes
containing viral transport medium (Viral transport media—provided by
laboratory bovine calf serum [62.5 mL], minimum essential media
[500 mL], Penicillin/Streptomycin [5 mL], and Gentamicin [500 lL]) and
transported to the laboratory (Real-time PCR Research and Diagnostics
Core Facility, School of Veterinary Medicine, Department of Medicine
and Epidemiology, 3110 Tupper Hall, University of California, Davis,
CA 95616) for sample processing and analysis. The nasal secretion
samples were stored at 48C until being processed and analyzed within
96 hours of collection.
2.3 | Sample processing and PCR analysis
Nucleic acid extraction from nasal secretions was performed using
an automated nucleic acid extraction system (CAS-1820 X-tractor
Gene, Corbett Life Science) according to the manufacturer’s recom-
mendations. Total RNA was purified from nasal secretions as fol-
lows: 20 lL of each freshly extracted nucleic acid sample from nasal
secretions (containing genomic DNA [gDNA] and total RNA) was
digested with DNAse for 60 minutes at 378C to remove gDNA.
DNase was inactivated at 958C for 5 minutes. Complementary DNA
from each sample was synthesized using 50 U SuperScript III (Invi-
trogen) in a 40 lL final volume containing 50 mM Tris-HCl, pH 8.3,
50 mM KCl, 8 mM MgCl2, 0.5 mM dNTPs, 40 U RNAsin, 0.5 mM
dithiothreitol, and 600 ng random hexadeoxyribonucleotide (pd [N]
6) primers (random hexamers, Invitrogen). The reaction was per-
formed at 508C for 60 minutes. After inactivation at 958C for 5
minutes, the reaction volume was adjusted to 100 lL with nuclease-
free water.
Nasal secretions were assayed for the presence of the EIV, EHV-1,
EHV-2, EHV-4 EHV-5, S. equi, ERAV, and ERBV using previously
reported quantitative TaqMan PCR assays.1,7 To determine the sample
quality and efficiency of nucleic acid extraction all samples were ana-
lyzed for the presence of the housekeeping gene equine glyceraldehyde-
3-phosphate dehydrogenase as previously described.8 The laboratory
defines failure of quality control as inadequate genomic material or the
presence of inhibitors of the qPCR reaction in samples.
2.4 | Data analysis
Most of the data is presented as descriptive results with population
proportions, percentages, or both being reported. Odds ratios were
calculated for differences between breed groups. Numerical data
was analyzed for normality using the Shapiro-Wilk test. Hematologic
variables were normally distributed and were compared using a one-
way ANOVA (VassarStat, Online version, Vassar College, Pough-
keepsie, New York). Horses were split into four groups for compari-
son of hematologic variables: PCR-positive nasal swab/respiratory
disease clinical signs positive, PCR-negative nasal swab/respiratory
disease clinical signs negative, PCR-positive nasal swab/respiratory
disease clinical signs negative, and PCR-negative nasal swab/respira-
tory disease clinical signs positive. A P-value of significance was set
at <.05.
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3 | RESULTS
One hundred sixty-seven individual horses were enrolled in the study.
The median age was 7 years with a range of 3 weeks-21 years. There
were no yearlings; however, there were 3 foals under the age of 1 year
(range 1–6 months) that were accompanying their dams. The popula-
tion included 161 mares, 6 stallions and no geldings. Breed groups rep-
resented were European warmbloods (79.0%; 132/167), Friesians
(8.4%; 14/167), baroque breeds (7.8%; 13/167), ponies (1.8%; 3/167),
and others (3.0%; 5/167). All of the horses in our study entered from
Europe with the majority coming from Germany (34.7%; 58/167), The
Netherlands (29.3%; 49/167), and Belgium (8.4%; 14/167) with smaller
percentages from Spain (6.0%; 10/167), The United Kingdom (4.8%; 8/
167), France (4.8%; 8/167), Ireland (3.6%; 6/167), Denmark (2.4%; 4/
167), Portugal (1.8%; 3/167), Italy (1.8%; 3/167), Sweden (1.2%; 2/
167), Switzerland (0.6%; 1/167), and Austria (0.6%; 1/167).
3.1 | Herpesviruses
g-Herpesviruses were more commonly recovered than
a-herpesviruses. Equine herpesvirus type-2 was found in 27.7% (48/
167) and EHV-5 was recovered from 40.7% (68/167) of horses. Of
horses shedding EHV-2 and EHV-5, 58.3% (28/48) and 64.7% (44/68)
were asymptomatic, respectively. Of horses shedding EHV-5, 38.2%
(26/68) were shedding viral loads greater than 650 000 gB genes/mil-
lion cells and of those horses 65.4% (17/26) were asymptomatic, simi-
lar to the percentage in the entire EHV-5 PCR-positive population. The
clinical signs in horses, qPCR positive for g-herpesvirses are summar-
ized in Table 1.
The gB gene for EHV-1 non-neuropathogenic (A2254 genotype)
was detected in nasal secretions from 1/167 horses on arrival (a 3-
week old filly) and in one additional animal (her dam) that developed
clinical signs during the quarantine period. Both the foal and her mare
had consistent clinical signs of tachypnea (respiratory rate 90–100
breaths per minute), mucoid nasal discharge, and fever (102.0–102.58F;
Table 1). The viral load was high in the filly with 1.4 3 107 EHV-1 gB
genes/million nasal cells. That filly was also positive in whole blood for
the EHV-1 gB genes (9.7 3 102 gB genes/million WBCs). The filly’s
dam was positive in low numbers in nasal swab associated with clinical
signs of respiratory disease (5.1 3 103 gB genes/million nasal cells) but
qPCR-negative in blood. These horses were Andalusians from Spain.
Both horses were still positive in nasal secretions at the time of dis-
charge from quarantine, approximately 14 days (filly) and 11 days (dam)
after onset of clinical signs, with recommendations to strictly quaran-
tine at their destination. Ultimately, 1.2% of the population was shed-
ding EHV-1 (A2254 genotype). Equine herpesvirus type-1
neuropathogenic (G2254 genotype) was not detected from any of the
horses in our study.
Equine herpesvirus type-4 was detected in 4/167 horses on arrival
at the quarantine facility and in one additional animal that developed a
fever during the quarantine period. In our study, 3.0% of horses in our
study were shedding EHV-4. Of the horses shedding EHV-4, 60.0% (3/
5) had clinical signs associated with respiratory disease and 40.0% (2/5)
were asymptomatic (Table 1). Friesians were more likely to shed EHV-
4 than European warmbloods (OR 7.17 [1.09–47.18] P5 .041). The
EHV-4 positive horses came from The Netherlands (2), Germany (1),
the United Kingdom (1), and Ireland (1). There was no significant effect
of country of origin on EHV-4 shedding.
All three foals enrolled in the study were qPCR-positive for her-
pesviruses on nasal swabs: EHV-1 (1), EHV-2 (2), and EHV-5 (2). All of
the foals were shedding viral loads greater than 1.8 3 106 gB genes/
million cells regardless of the type of herpesvirus. As a comparison, the
median viral load for horses 2 years was 1.8 3 104 gB genes/million
cells. Two foals had coinfections (EHV-1/EHV-5 and EHV-2/EHV-5)
and one foal was only positive for EHV-2. The two foals with coinfec-
tions both had clinical signs associated with infectious respiratory dis-
ease, whereas the foal shedding only EHV-2 was asymptomatic.
Twenty-eight adult horses were qPCR positive for multiple herpes-
viruses: EHV-2 and EHV-5 (25/28), EHV-1 and EHV-5 (1/28), and
EHV-2, EHV-4, and EHV-5 (2/28). In horses with co-infections, 42.9%
(12/28) had clinical signs associated with respiratory disease and 57.1%
(16/28) were asymptomatic.
Of the nasal swab samples submitted for herpesvirus qPCR, 6.0%
(10/167) for a-herpesviruses and 6.6% (11/167) for g-herpesviruses,
failed quality control, respectively.
3.2 | RNA viruses
Neither EIV nor ERVs were detected from any of the enrolled horses.
However, a higher percentage of the nasal swab samples submitted
failed quality control for the RNA viruses (25.1%, 42/167) than the
DNA viruses (6.6%) and S. equi (7.2%). None of the horses that failed
quality control had clinical signs consistent with equine influenza or
equine rhinitis virus infection. There was a seasonal bias to the quality
control failure with the late summer, early autumn months having the
highest percentage failure (July 44.4%, August 42.9%, September
73.7%, and October 72.6%). Quality control failure rate was <20% for
all the other months. The summer and fall months in Davis, CA are
TABLE 1 Clinical signs: Summary of clinical signs seen in horses










Fever (n5 11) 2 2 2 5
Tachypnea (n5 9) 2 1 1 5
Cough (n5 5) 0 0 2 3
Enlarged lymph
nodes (n511)
0 0 6 5
Abnormal lung
sounds (n50)
0 0 0 0
Nasal discharge
(n542)
2 1 16 23
No clinical signs
(n574)
0 2 28 44
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typically hot and dry with presence of high levels of dust and particu-
late matter in the air.
3.3 | Streptococcus equi subspecies Equi
Streptococcus equi was not recovered by qPCR from any nasal secre-
tions. However, 12/167 horses failed quality control, including one
horse with enlarged submandibular lymph nodes. One horse with fever
and enlarged submandibular lymph nodes had multiple nasal swabs
taken during the quarantine period and all came were negative for S.
equi; however, it was reported to be bacterial culture positive from a
lymph node aspirate performed after release from quarantine.
3.4 | Hematologic variables
There were no significant differences in mean hematocrit (P5 .11),
WBC (P5 .39), neutrophil count (P5 .95), lymphocyte count (P5 .092),
monocyte count (P5 .18), or fibrinogen (P5 .80) between the four
groups of horses as previously defined (Table 2).
4 | DISCUSSION
Our study demonstrated that equine herpesviruses are frequently
detected in horses recently imported into the United States after long
distance travel. Recognized equine respiratory herpesviruses were
detected by qPCR in 52.1% (87/167) of the study horses this included
EHV-2 (28.7%), EHV-5 (40.7%), and EHV-1 or EHV-4 in 4.2%. The
EHV-1 qPCR-positive horses all displayed clinical signs of respiratory
disease. Horses that were qPCR-positive for EHV-2, EHV-4, and EHV-
5 did not predictably exhibit clinical signs of respiratory disease. None
of the study horses were found to be qPCR-positive for EIV, ERAV,
ERBV, or S. equi.
Our study found that g-herpesviruses were commonly shed by
large numbers of horses and that a-herpesviruses were shed by only
4.2% of the horses. The role g-herpesviruses play in the development
of respiratory disease has remained poorly understood. Equine
herpesvirus-2 has been associated with outbreaks of upper respiratory
tract disease in young horses9, but EHV-2 has also been isolated from
clinically normal horses.10 Equine herpesvirus-5 has been associated
with the development of multinodular pulmonary fibrosis (EMPF),11
herpetic ocular disease,12 and lymphoma13 in horses, however, these
diseases are rare while of EHV-5 shedding in the equine population is
common.14 It has previously been reported that horses with nasal
secretion viral loads of >650 000 gB genes/million cells were more
likely to have EMPF than controls.15 Interestingly, 38.2% of EHV-5
qPCR positive horses in our study were shedding >650 000 gB genes/
million cells. This elucidates the importance of clinical findings on inter-
pretation of diagnostics and demonstrates that other factors such as
travel stress and host-related factors are likely to play a role in the
magnitude of viral shedding.
Our study showed that Friesian horses were more likely to shed
EHV-4 than European warmbloods. A previous study looking at
increased rectal temperature in horses during the first 48 hours of
quarantine at US air import facilities found that Friesians were signifi-
cantly more likely than warmbloods to have an increased rectal temper-
ature during that time period.16 Friesians have been shown to have a
higher inbreeding coefficient that most other equine breeds including
European warmbloods.17,18 Inbreeding has been associated with
increased susceptibility to disease in many species. In humans,
increased susceptibility to herpes simplex virus-1 infection has been
demonstrated to be heritable.19
Our study only had three foals; however, all were qPCR-positive
for herpesvirus and were shedding very high viral numbers. Further
investigation of viral shedding in transported foals is warranted. Previ-
ous surveillance studies in nontransported foals reported that <25% of
the nasal swabs were found to contain herpesviruses.20
Equine influenza virus and ERVs were not detected in any horses
in our study; however, 27.5% (46/167) of the samples failed quality
control. Reasons for quality control failure may have been associated
with inhibition within the sample, inadequate amount, or quality of
genomic material, or DNA/RNA degradation. Inhibition within the sam-
ple can be caused by organic material that may obscure qPCR analysis,
compounds that can inhibit the reactions (eg, cell lies) or bind genomic
material (RNA/DNA).21 The seasonal distribution of quality control fail-
ure is suggestive that there are environmental factors that may contrib-
ute to the inhibition. The months with the highest failure of quality
control are the driest, dustiest, and warmest months in the study loca-
tion, likely leading to considerable contamination of the nasal passages
with organic debris and dust. It would be expected that inadequate
TABLE 2 Hematologic parameters—groups are defined as PCR-positive nasal swab/respiratory disease clinical signs positive (PCR1/CS1),
PCR-negative nasal swab/respiratory disease clinical signs positive (PCR–/CS1), PCR-positive nasal swab/respiratory disease clinical signs
negative (PCR1/CS–), and PCR-negative nasal swab/respiratory disease clinical signs negative (PCR–/CS–)
Parameter
Mean (SD) PCR1/CS1 (n531) PCR–/CS1 (n5 56) PCR1/CS– (n519) PCR–/CS– (n526) One-way ANOVA
Hematocrit (%) 35.2 (4.2) 35.8 (4.3) 37.8 (2.7) 35.2 (4.0) P5 .11
White blood cells/lL 8598 (2100) 7901 (1984) 8021 (1557) 8275 (1489) P5 .39
Neutrophils/lL 5204 (1334) 5107 (1317) 5271 (1325) 5246 (1208) P5 .95
Lymphocytes/lL 2929 (1466) 2364 (961) 2378 (719) 2605 (766) P5 .092
Monocytes/lL 340 (210) 295 (109) 252 (112) 296 (107) P5 .18
Fibrinogen (mg/dL) 281 (120) 267 (102) 258 (84) 269 (84) P5 .80
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genomic material as a cause of quality control failure should not have a
seasonal distribution. All of our samples were kept refrigerated in a viral
culture media before processing to try to reduce DNA/RNA degrada-
tion; however, RNA is more sensitive to degradation than DNA. While
we had a fairly high percentage of samples fail quality control, none of
those horses had clinical signs typically associated with EIV, ERAV, or
ERBV infection such as cough, fever, or tachypnea.
No horses were positive for S. equi, although 12 failed quality con-
trol. Of the horses that failed quality control, one had clinical signs con-
sistent with strangles (enlarged lymph nodes and nasal discharge). In a
clinical setting, it would have been prudent to collect a second sample
for testing. Additionally, there was a single horse with consistent clini-
cal signs, found to be negative on multiple nasal swabs, which was later
found to be culture positive from a lymph node aspirate. It is currently
recognized that nasal swabs are not as sensitive for recovery of S. equi
as guttural pouch lavage or pharyngeal wash samples.22,23 It is recom-
mended that in clinical cases with consistent signs the type of sample
collected should be adjusted to maximize the chances of recovery.
In our study, complete blood count was not useful in the identifica-
tion of horses shedding herpesviruses with or without the presence of
clinical signs. It has previously been reported that horses with EHV-1
infections had an elevation in absolute monocyte count within the first
5 days of disease and increased neutrophil to lymphocytes ratios early
in disease followed by a decrease later in the course of disease.24 It
may be that hematologic measurements over time may be more helpful
in linking respiratory signs to a viral infection.
The study had several limitations. First the study population was
only composed of mares and stallions 2 years of age and older, and a
few nursing foals entering the CEM quarantine facility. Geldings
imported from outside the United States and weaned fillies and colts
<2 years or age were not available for testing as they directly enter
the United States from the port of entry quarantine facility. The pro-
posed study horses represent 20% of all horses imported through the
USDA import facility located in Los Angeles. Based on the results of
horses <2 years of age in our study this may represent a higher risk
population that the general population of imported horses. Horses <2
years of age have been shown to be significantly more likely to have an
increased rectal temperature than horses >2 years of age after arrival
at an air import facilities in the United States.16 Further investigation of
respiratory pathogen shedding by young imported horses is warranted.
Additionally, because sampling took place at a secondary quaran-
tine site the horses were sampled 72 hours after arrival in the coun-
try. It is possible that we missed horses that were shedding during the
initial three days after air transport. We do not know if there is a differ-
ence in air versus overland travel for transmission of respiratory patho-
gens in horses. There is some evidence to suggest that horses are more
stressed in air travel based on heart rate and heart rate variability.25 In
humans, air transportation appears important in influenza propagation
and it is likely that ground transport systems and transport hubs play a
role in influenza propagation.26
Another limitation relates to the number of study horses. There is
minimal data showing the expected frequency of shedding of common
and lesser-characterized respiratory pathogens from horses recently
imported into the United States. Equine herpesvirus type-1 shedding
via nasopharyngeal swabs or blood was found in only 1% of horses in a
population very similar to our study. Studies investigating the shedding
of common respiratory pathogens in healthy horses attending various
equine events or sales have shown 2–4% of horses shedding at least
one of the respiratory pathogens.1,2,26
Imported horses traveling long distances represent a considerable
risk for spreading infectious respiratory pathogens into horse popula-
tions. Herpesviruses are commonly shed by imported horses, and
young horses and some breeds may represent a higher risk. It is impor-
tant to note that clinical signs were poorly correlated with being qPCR-
positive for EHV-2, EHV-4, or EHV-5. The lack of clinical signs in
horses with herpes viral infection increases the risk of introducing a
shedding horse into a susceptible population. These findings demon-
strate the need for rigorous biosecurity measures when introducing
recently imported horses into resident equine populations.
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